About the journal
PPAR Research is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,790 USD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 1687-4757 · 1687-4765
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,790 USD
- Articles in DOAJ
- 629
- Declared review time
- 12 weeks
- Declared peer-review model
- peer_review
- Official website
- https://onlinelibrary.wiley.com/journal/1751
Index listings
- DOAJ · 2006-06-30
- Indexing
- DOAJ
- APC
- 1,790 USD
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
629
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
693
Last recorded publication year
2026
h-index
71
i10-index
520
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2006-06-30
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMCPorticoCLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 82%
- ORCID iDs in current deposits
- 73%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Peroxisome proliferator-activated receptor research
- Source type
- journal
- NLM unique ID (PubMed)
- 101269101
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Peroxisome Proliferator-Activated Receptors
- Peroxisome Proliferator-Activated Receptors
- Adipose Tissue and Metabolism
- Adipose Tissue and Metabolism
- Metabolism, Diabetes, and Cancer
- Metabolism, Diabetes, and Cancer
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
Show all subjects (50)
- Eicosanoids and Hypertension Pharmacology
- Eicosanoids and Hypertension Pharmacology
- Inflammatory mediators and NSAID effects
- Inflammatory mediators and NSAID effects
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
- Adipokines, Inflammation, and Metabolic Diseases
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Cardiovascular Function and Risk Factors
- NF-κB Signaling Pathways
- NF-κB Signaling Pathways
- Cardiovascular Function and Risk Factors
- Retinoids in leukemia and cellular processes
- Retinoids in leukemia and cellular processes
- Cancer-related gene regulation
- Cancer-related gene regulation
- Lipid metabolism and biosynthesis
- RNA modifications and cancer
- Diabetes Treatment and Management
- RNA modifications and cancer
- Diabetes Treatment and Management
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Lipid metabolism and biosynthesis
- Immune cells in cancer
- Immune cells in cancer
- Cholesterol and Lipid Metabolism
- Cholesterol and Lipid Metabolism
- Lipid metabolism and disorders
- Metabolism and Genetic Disorders
- Metabolism and Genetic Disorders
- Lipid metabolism and disorders
- Pancreatic function and diabetes
- Pancreatic function and diabetes
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
Keywords (DOAJ)
- ppar alpha
- ppar-beta
- ppar delta
- ppar gamma
- peroxisome proliferator-activated receptors
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ